{
    "nctId": "NCT06039644",
    "briefTitle": "To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer",
    "officialTitle": "To Evaluate the Efficacy of Probiotics in Improvement and Prevention of Chemotherapy Associated Side Effectes in Patients With the Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Change from 12 weeks in the chemotherapy associated side-effects questionnaire at 24 weeks",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Stage I-III breast patients using anthracycline-based and taxane-based chemotherapy (not limited before or after chemotherapy/surgery)\n* BMI \\> 18 kg/m\\^2\n* Age between 20 and 80 years old\n* Patients judged by physicians to participate in this trial and who are willing\n\nExclusion Criteria:\n\n* Pregnant or lactating female patients\n* Patients with bariatric surgery, gastrointestinal resections, Crohn's disease, celiac disease\n* BMI \\< 18 kg/m\\^2\n* Patient who have severe allergy to soybeans or peanuts\n* Those who are under 20 years old or over 80 years old",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}